drugset / Trial / NCT00108979

Study of Escitalopram in Adult Patients With Major Depressive Disorder

NCT00108979

Phase 3 Completed 240 enrolled Forest Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

Escitalopram is the S-enantiomer of citalopram. Both escitalopram and citalopram are selective serotonin reuptake inhibitors (SSRIs) and are used to treat depression in adults. This study is designed to evaluate the efficacy, safety, and pharmacoeconomics of escitalopram and an active comparator in patients with major depressive disorder.

Timeline

Start
2005-03
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule